Table: Kobayashi Pharmaceutical - 6-MTH group results
Jul 31 (Reuters)-
Kobayashi Pharmaceutical Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2019 Jun 30, 2018 Dec 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 73.63 72.68 173.00
(+1.3 pct) (+8.0 pct) (+3.3 pct)
Operating 11.42 11.60 27.30
(-1.6 pct) (+12.0 pct) (+3.8 pct)
Recurring 11.64 11.53 27.90
(+0.9 pct) (+12.6 pct) (+1.9 pct)
Net 8.20 7.63 19.00
(+7.5 pct) (+8.4 pct) (+5.4 pct)
EPS 104.26 yen 96.58 yen 240.29 yen
EPS Diluted 96.50 yen
Ann Div 66.00 yen 68.00 yen
-Q2 div 33.00 yen 31.00 yen
-Q4 div 35.00 yen 35.00 yen
NOTE - Kobayashi Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows